Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters

Kristine E. Kokeny, Samual Francis, Randa Tao, Ying J. Hitchcock


We appreciate the comments from Zhao and Ng (1) regarding our recent National Cancer Database (NCDB) study comparing survival outcomes after postoperative adjuvant concurrent chemoradiotherapy (CRT) versus sequential chemotherapy followed by postoperative radiotherapy (C→PORT) for locally advanced or incompletely resected non-small cell lung cancer (NSCLC).